MCID: NRR001
MIFTS: 39

Neuroretinitis

Categories: Eye diseases, Neuronal diseases

Aliases & Classifications for Neuroretinitis

MalaCards integrated aliases for Neuroretinitis:

Name: Neuroretinitis 12 15 73
Juxtapapillary Focal Retinitis and Retinochoroiditis 12 73
Retinitis 44 73
Focal Retinitis and Retinochoroiditis, Juxtapapillary 12
Papilloretinitis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10176
ICD10 33 H30.9
MeSH 44 D012173

Summaries for Neuroretinitis

MalaCards based summary : Neuroretinitis, also known as juxtapapillary focal retinitis and retinochoroiditis, is related to retinal hemangioblastoma and optic disk drusen. An important gene associated with Neuroretinitis is EXTL3 (Exostosin Like Glycosyltransferase 3). The drugs Lidocaine and Gabapentin have been mentioned in the context of this disorder. Affiliated tissues include lymph node, eye and retina, and related phenotypes are homeostasis/metabolism and endocrine/exocrine gland

Wikipedia : 76 Cat-scratch disease (CSD) is an infectious disease that results from a scratch or bite of a cat.... more...

Related Diseases for Neuroretinitis

Diseases related to Neuroretinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1809)
# Related Disease Score Top Affiliating Genes
1 retinal hemangioblastoma 32.8 VEGFA LYZ CD274 CA2
2 optic disk drusen 31.4 VEGFA UBL4A
3 cancer-associated retinopathy 30.3 VEGFA RCVRN
4 retinal artery occlusion 30.1 VEGFA ACE
5 multiple sclerosis 29.8 MOG IFNB1 CTLA4 AQP4
6 relapsing-remitting multiple sclerosis 29.6 MOG IFNB1 AQP4
7 autoimmune optic neuritis 29.5 RCVRN MOG DPYSL5 AQP4
8 demyelinating disease 29.4 MOG IFNB1 AQP4
9 central nervous system disease 29.4 MOG IFNB1 AQP4
10 myelitis 29.3 MOG AQP4
11 nervous system disease 29.1 VEGFA MOG IFNB1 AQP4 ACE
12 optic nerve disease 29.1 UBL4A MOG IFNB1 DPYSL5 AQP4
13 retinitis pigmentosa 3 12.5
14 retinitis pigmentosa 27 12.4
15 retinitis pigmentosa 12 12.4
16 doyne honeycomb retinal dystrophy 12.4
17 retinitis pigmentosa 9 12.4
18 retinitis pigmentosa 2 12.4
19 retinitis pigmentosa 11 12.4
20 retinitis pigmentosa 4 12.4
21 retinitis pigmentosa 1 12.4
22 retinitis pigmentosa 28 12.4
23 retinitis pigmentosa 13 12.4
24 retinitis pigmentosa 17 12.4
25 retinitis pigmentosa 30 12.4
26 retinitis pigmentosa 18 12.3
27 late-onset retinal degeneration 12.3
28 retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities 12.3
29 retinitis pigmentosa 10 12.3
30 retinitis pigmentosa 51 12.3
31 retinitis pigmentosa 55 12.3
32 retinitis pigmentosa 45 12.3
33 retinal disease 12.3
34 central retinal artery occlusion 12.3
35 retinal vascular occlusion 12.3
36 cytomegalovirus retinitis 12.3
37 neuropathy, ataxia, and retinitis pigmentosa 12.3
38 retinitis pigmentosa 7 12.3
39 infantile cerebellar-retinal degeneration 12.3
40 retinitis pigmentosa 50 12.3
41 posterior column ataxia with retinitis pigmentosa 12.3
42 retinal arteries, tortuosity of 12.3
43 retinitis pigmentosa 41 12.3
44 retinitis pigmentosa 67 12.3
45 vasculopathy, retinal, with cerebral leukodystrophy 12.3
46 retinitis pigmentosa 38 12.3
47 retinitis pigmentosa 14 12.3
48 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 12.3
49 retinitis pigmentosa 19 12.3
50 retinitis pigmentosa 25 12.3

Graphical network of the top 20 diseases related to Neuroretinitis:



Diseases related to Neuroretinitis

Symptoms & Phenotypes for Neuroretinitis

MGI Mouse Phenotypes related to Neuroretinitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10 ACE AQP4 CA2 CD274 CTLA4 EXTL3
2 endocrine/exocrine gland MP:0005379 9.97 ACE AQP4 CA2 CTLA4 EXTL3 LYZ
3 hematopoietic system MP:0005397 9.97 ACE AQP4 CD274 CTLA4 IFNB1 LYZ
4 immune system MP:0005387 9.85 ACE AQP4 CA2 CD274 CTLA4 IFNB1
5 mortality/aging MP:0010768 9.65 ACE AQP4 CA2 CD274 CTLA4 EXTL3
6 no phenotypic analysis MP:0003012 9.17 AQP4 CD274 IFNB1 LYZ TNFRSF10A UBL4A

Drugs & Therapeutics for Neuroretinitis

Drugs for Neuroretinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 438)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 137-58-6 3676
2
Gabapentin Approved, Investigational Phase 4,Phase 3,Not Applicable 60142-96-3 3446
3
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
4
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
5
Dopamine Approved Phase 4,Not Applicable 51-61-6, 62-31-7 681
6
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 447043
7
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Early Phase 1 437-38-7 3345
9
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
10
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
11
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
12
Doxycycline Approved, Investigational, Vet_approved Phase 4,Not Applicable 564-25-0 54671203
13
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
14
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
15
Aluminum hydroxide Approved, Investigational Phase 4 21645-51-2
16
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
17
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
18
Imipramine Approved Phase 4 50-49-7 3696
19
Pregabalin Approved, Illicit, Investigational Phase 4,Not Applicable 148553-50-8 5486971
20
Morphine Approved, Investigational Phase 4,Phase 3,Not Applicable 57-27-2 5288826
21
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 302-25-0
22
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 83-43-2 6741
23
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-24-8 5755
24
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 3,Not Applicable 2921-57-5
25
Clozapine Approved Phase 4 5786-21-0 2818
26
Insulin Detemir Approved Phase 4 169148-63-4 5311023
27
Zinc Approved, Investigational Phase 4 7440-66-6
28
4-Aminopyridine Approved Phase 4 504-24-5 1727
29
Caffeine Approved Phase 4,Not Applicable 58-08-2 2519
30
Levonorgestrel Approved, Investigational Phase 4,Not Applicable 17489-40-6, 797-63-7 13109
31
Tamoxifen Approved Phase 4 10540-29-1 2733526
32
Capsaicin Approved Phase 4 404-86-4 1548943
33
Ticagrelor Approved Phase 4 274693-27-5 9871419
34
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
35
Methylnaltrexone Approved Phase 4 83387-25-1, 916055-93-1 6603824
36 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 979-32-8
37
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-28-2 5757
38
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Not Applicable 28014-46-2
39
Sirolimus Approved, Investigational Phase 4,Phase 2,Not Applicable 53123-88-9 46835353 6436030 5284616
40
Isoniazid Approved, Investigational Phase 4,Phase 3,Phase 2 54-85-3 3767
41
Rifapentine Approved, Investigational Phase 4,Phase 2 61379-65-5 6323497
42
Rifampicin Approved Phase 4,Phase 3,Phase 2 13292-46-1 5458213 5381226
43
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 14219 4091
44
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
45
Piperacillin Approved Phase 4 66258-76-2 43672
46
Tazobactam Approved Phase 4 89786-04-9 123630
47
Remifentanil Approved Phase 4 132875-61-7 60815
48
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
49
Haloperidol Approved Phase 4 52-86-8 3559
50
Furosemide Approved, Vet_approved Phase 4,Phase 1 54-31-9 3440

Interventional clinical trials:

(show top 50) (show all 457)
# Name Status NCT ID Phase Drugs
1 Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Unknown status NCT02484105 Phase 4
2 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4 Gabapentin;S-ketamine;Lidocaine;Droperidol
3 Optimal Multimodal Analgesia in Abdominal Hysterectomy Unknown status NCT00209872 Phase 4 Gabapentin;Lidocaine;S-ketamine
4 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
5 SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents Unknown status NCT00714545 Phase 4
6 Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety. Unknown status NCT02226328 Phase 4 Propofol sedation;Midazolam and Fentanyl sedation
7 Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair Unknown status NCT01326039 Phase 4 bupivacaine;saline
8 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
9 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
10 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
11 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4 Imipramine;Pregabalin;Imipramine, pregabalin;Placebo
12 Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair Unknown status NCT00960011 Phase 4
13 Santyl vs. Sharp Debridement of Diabetic Foot Wounds Completed NCT01056198 Phase 4 Santyl
14 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Completed NCT02625103 Phase 4 Clozapine
15 Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Completed NCT01308554 Phase 4 Placebo: sterile normal saline;Marcaine
16 Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients Completed NCT00742976 Phase 4 Insulin Detemir; Insulin Insulatard;Insulin Detemir, Insulin Insulatard
17 Resistance Training and Amino Pyridine in Multiple Sclerosis Completed NCT02143167 Phase 4 SR-fampridine;Placebo
18 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Completed NCT01656148 Phase 4 Fampridine-SR
19 Effects of NSK-SD (Nattokinase) on Blood Pressure Completed NCT02886507 Phase 4
20 The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods Completed NCT01048515 Phase 4 Caffeine
21 Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy Completed NCT01934088 Phase 4 Propofol;Midazolam;Fentanyl
22 Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) Completed NCT02824224 Phase 4 Tamoxifen;Placebo (for Tamoxifen)
23 Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls Completed NCT00115102 Phase 4 fentanyl;S-ketamine
24 The Effect of Calcium and Vitamin D in Patients With Heart Failure Completed NCT00497900 Phase 4 Vitamin D
25 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4 Hormone replacement therapy
26 Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients Completed NCT02942550 Phase 4 Methylnaltrexone bromide (Relistor®).;Sodium Chloride 9mg/mL
27 Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome Completed NCT00134745 Phase 4 estradiol
28 The SORT OUT IX STEMI OCT Trial Recruiting NCT02915107 Phase 4
29 Corticosteroid Reduction in COPD Recruiting NCT02857842 Phase 4 Prednisolone
30 Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease Recruiting NCT03262142 Phase 4 Piperacillin/tazobactam;Ciprofloxacin
31 Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children Recruiting NCT03460002 Phase 4
32 Treatment of Latent Tuberculosis in Socially Marginalised Citizens Recruiting NCT03266991 Phase 4 Rifapentine;Isoniazid
33 Volatile Anesthetic Protection Of Renal Transplants 2 Recruiting NCT02727296 Phase 4 sevoflurane;propofol
34 Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis Recruiting NCT02831608 Phase 4
35 Treat-to-target With Secukinumab in Axial Spondyloarthritis Recruiting NCT03639740 Phase 4 Secukinumab 150 milligram [Cosentyx]
36 Pan European Collaboration on Antipsychotic Naïve Schizophrenia II Recruiting NCT02339844 Phase 4 Aripiprazole
37 Agents Intervening Against Delirium in Intensive Care Unit Recruiting NCT03392376 Phase 4 Haloperidol Injection
38 BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Active, not recruiting NCT02623140 Phase 4
39 Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Active, not recruiting NCT02797340 Phase 4 Metformin
40 The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting Not yet recruiting NCT01534221 Phase 4
41 Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas Not yet recruiting NCT03782155 Phase 4 glutamine supplementation;HMB;Placebo
42 The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study Terminated NCT01899235 Phase 4
43 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
44 Morphine, Dyspnea, Exercise and COPD Unknown status NCT01718496 Phase 3 Morphine;Placebo
45 Trial for Single Port Versus Conventional Laparoscopic Colectomy Unknown status NCT01101672 Phase 2, Phase 3
46 Adjuvant Whole Breast Radiotherapy (RT) With Intensity Modulated Radiotherapy (IMRT) and a Simultaneous Integrated Boost Versus Conventional RT and a Sequential Boost Unknown status NCT01322854 Phase 3
47 Lung Protective Ventilation During Robotic Assisted Prostatectomy Completed NCT02551341 Phase 3
48 Nucleoplasty for Contained Herniated Lumbar Discs Completed NCT00124774 Phase 3
49 Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial Completed NCT01304927 Phase 2, Phase 3 Cholecalciferol and calcium
50 The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET Completed NCT00747968 Phase 2, Phase 3 Byetta, Exenatide

Search NIH Clinical Center for Neuroretinitis

Cochrane evidence based reviews: retinitis

Genetic Tests for Neuroretinitis

Anatomical Context for Neuroretinitis

MalaCards organs/tissues related to Neuroretinitis:

41
Lymph Node, Eye, Retina, Brain, Kidney, Heart, T Cells

Publications for Neuroretinitis

Articles related to Neuroretinitis:

(show top 50) (show all 315)
# Title Authors Year
1
Bartonella henselaeA neuroretinitis in patients without cat scratch. ( 29962482 )
2018
2
Multimodal imaging questions etiology of idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome (IRVAN syndrome). ( 29406987 )
2018
3
Bilateral neuroretinitis due to Bartonella henselae in a child. ( 29631847 )
2018
4
Recurrent idiopathic neuroretinitis as a spectrum of atypical optic neuritis: a case report and literature review. ( 29538599 )
2018
5
Pathogenesis of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) or 'idiopathic retinal arteriolar aneurysms (IRAA)' with macular star. ( 29447942 )
2018
6
A new perspective for analyzing clinical characteristics of idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 29934930 )
2018
7
Resolution of arterial aneurysms in idiopathic retinal vasculitis, aneurysms and neuroretinitis: a case report and review of literature. ( 29594790 )
2018
8
Long-term outcomes in a series of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome. ( 30340706 )
2018
9
Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? ( 30326075 )
2018
10
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 30038179 )
2018
11
Molecular diagnosis and ocular imaging of varicella zoster virus associated neuroretinitis. ( 30094392 )
2018
12
Neuroretinitis: a review. ( 30148725 )
2018
13
Case report: a case of diffuse unilateral subacute neuroretinitis (DUSN) in a child. ( 30255794 )
2018
14
Evolution of a severe case of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) during pregnancy. ( 30389182 )
2018
15
Toxocara Neuroretinitis Associated with Raw Meat Consumption. ( 30405949 )
2018
16
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) in a Patient Without IRVAN History. ( 30419083 )
2018
17
Neuroretinitis as presenting and the only presentation of Lyme disease: Diagnosis and management. ( 28440258 )
2017
18
TREATMENT OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS (IRVAN) WITH PHOTOCOAGULATION IN COMBINATION WITH SYSTEMIC IMMUNOSUPPRESSION. ( 29261555 )
2017
19
Unilateral neuroretinitis. ( 28416231 )
2017
20
Neuroretinitis Secondary to Bartonella Henselae in a Patient with Myelinated Retinal Nerve Fibers: Diagnostic Dilemmas and Treatment. ( 29283743 )
2017
21
Diffuse Unilateral Subacute Neuroretinitis Caused by Ancylostoma Hookworm. ( 28098549 )
2017
22
BARTONELLA HENSELAE NEURORETINITIS ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION, CHOROIDAL ISCHEMIA, AND ISCHEMIC OPTIC NEUROPATHY. ( 28700390 )
2017
23
UNILATERAL NEURORETINITIS AS A LATE-ONSET MANIFESTATION OF THE CHIKUNGUNYA FEVER: A CASE SERIES. ( 28957957 )
2017
24
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. ( 29062224 )
2017
25
A case of suspected symptomatic Zika Neuroretinitis. ( 28736717 )
2017
26
Optical coherence tomography angiography of diffuse unilateral subacute neuroretinitis. ( 29260087 )
2017
27
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome Presenting With Branch Retinal Artery Occlusion. ( 29121367 )
2017
28
Optical Coherence Tomography in Neuroretinitis: Epipapillary Infiltrates and Retinal Folds. ( 28418948 )
2017
29
Full-thickness macular hole: a rare complication of Borrelia burgdorferi neuroretinitis. ( 28473358 )
2017
30
Ultrawide field imaging with navigable magnifier for diagnosis of diffuse unilateral subacute neuroretinitis. ( 29269373 )
2017
31
BARTONELLA QUINTANA-ASSOCIATED NEURORETINITIS: LONGITUDINAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHIC FINDINGS. ( 27258542 )
2016
32
Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient. ( 27525478 )
2016
33
Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in BehAset's Disease. ( 27065852 )
2016
34
Choroidal neovascularization complicating optic disc drusen, mistaken for Bartonella neuroretinitis. ( 27730317 )
2016
35
Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient presenting with idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 26922651 )
2016
36
Diffuse Unilateral Subacute Neuroretinitis From Raccoon Exposure Resistant to Laser Photocoagulation. ( 27434904 )
2016
37
Fluorescein Photodiagnosis of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome: A Case Report and Long-Term Outcome of Photocoagulation Therapy. ( 27491854 )
2016
38
Toxoplasmosis Neuroretinitis: A Case Report. ( 27340559 )
2016
39
Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. ( 27195096 )
2016
40
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma. ( 27165193 )
2016
41
Bilateral neovascular glaucoma in idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 27085273 )
2016
42
Idiopathic retinal vasculitis, aneurysms and neuroretinitis case report. ( 29503895 )
2016
43
Bilateral stellate neuroretinitis revealing a pheochromocytoma. ( 25995810 )
2015
44
Clinical experience in treatment of diffuse unilateral subretinal neuroretinitis. ( 26491239 )
2015
45
Teaching NeuroImages: Cat-scratch optic neuropathy without neuroretinitis. ( 26078406 )
2015
46
Full-thickness macular hole in Bartonella henselae neuroretinitis in an 11-year-old girl. ( 25709274 )
2015
47
Optical Coherence Tomography Features in Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis Syndrome. ( 26425325 )
2015
48
Re: An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292953 )
2015
49
A rare case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome. ( 26265851 )
2015
50
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome. ( 26441263 )
2015

Variations for Neuroretinitis

Expression for Neuroretinitis

Search GEO for disease gene expression data for Neuroretinitis.

Pathways for Neuroretinitis

GO Terms for Neuroretinitis

Cellular components related to Neuroretinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.02 ACE AQP4 CD274 CTLA4 MOG

Biological processes related to Neuroretinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 kidney development GO:0001822 9.13 ACE CA2 VEGFA
2 positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086 8.62 ACE VEGFA

Sources for Neuroretinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....